| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0006 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.002 |